UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 07/2007, Volume 357, Issue 1, pp. 39 - 51
Biological and medical sciences | General aspects | Medical sciences | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Receptor, ErbB-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Signal Transduction - drug effects | Antineoplastic Agents - adverse effects | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - immunology | Chemotherapy, Adjuvant | Receptor, ErbB-2 - analysis | Receptor, ErbB-2 - drug effects | Trastuzumab | Drug therapy | Breast cancer | Index Medicus | Abridged Index Medicus
Journal Article
The oncologist (Dayton, Ohio), ISSN 1083-7159, 01/2011, Volume 16, Issue S1, pp. 1 - 11
Poly(ADP‐ribose) polymerase | Triple‐negative breast cancer | Basal‐like breast cancer | Chemotherapy | Epidermal growth factor receptor | Androgen receptor | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - therapy | Receptors, Estrogen - metabolism | Breast Neoplasms - genetics | Receptor, ErbB-2 - genetics | Breast Neoplasms - pathology | Humans | Receptor, ErbB-2 - metabolism | Female | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 21, pp. 2079 - 2080
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Female | Breast Neoplasms - genetics | Neoplasm Recurrence, Local - prevention & control | Breast Neoplasms - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Humans | Care and treatment | Chemotherapy | Usage | Breast cancer | Management | Public health | Cancer | Standardization | Clinical trials | Metastases | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Annual review of medicine, ISSN 0066-4219, 1/2015, Volume 66, Issue 1, pp. 297 - 309
metabolic syndrome | macrophages | inflammation | body mass index | cancer risk | adipose tissue | insulin resistance | adipocytes | Neoplasms - metabolism | Cytokines - metabolism | Humans | Insulin Resistance | Lipid Metabolism | Adipokines - metabolism | Obesity - metabolism | Adipose Tissue - metabolism | Inflammation - metabolism | Insulin - metabolism | Androgens - metabolism | Estrogens - metabolism | Insulin-Like Growth Factor I - metabolism | Obesity | Complications and side effects | Research | Oncology, Experimental | Cancer | Correlation analysis | Medical prognosis | Risk factors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 8, pp. 790 - 791
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Combined Modality Therapy | Chemotherapy, Adjuvant | Breast Neoplasms - drug therapy | Care and treatment | Usage | Breast cancer | Diagnosis | Adjuvant treatment | Cancer | Chemotherapy | Cytotoxicity | Genetic testing | Metastasis | Patients | Tumors | Metastases | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 55 - 65
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Predictive Value of Tests | Recurrence | United States - epidemiology | Breast Neoplasms - secondary | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Receptors, Estrogen - analysis | Genetic Testing - methods | Cyclophosphamide - therapeutic use | Patient Selection | Fluorouracil - therapeutic use | Breast Neoplasms - chemistry | Clinical Trials, Phase III as Topic | Time Factors | Postmenopause | Adult | Female | Retrospective Studies | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Chemotherapy | Cyclophosphamide | Clinical trials | genomics | Breast cancer | Tamoxifen | Doxorubicin | Survival | Nodes | Post-menopause | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 19, pp. 2382 - 2387
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Breast Neoplasms - surgery | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Biomarkers, Tumor - analysis | Humans | Kaplan-Meier Estimate | Treatment Outcome | Receptors, Estrogen - analysis | Breast Neoplasms - drug therapy | Breast Neoplasms - therapy | Breast Neoplasms - chemistry | Time Factors | Breast Neoplasms - pathology | Mastectomy, Segmental | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Aged, 80 and over | Breast Neoplasms - mortality | Female | Aged | Neoplasm Staging | Odds Ratio | Radiotherapy, Adjuvant - utilization | Index Medicus | Bc4 | Bc3 | Bc6 | ORIGINAL REPORTS | Bc7
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 07/2017, Volume 318, Issue 2, pp. 197 - 198
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Symptom Assessment | Neoplasms - mortality | Male | Randomized Controlled Trials as Topic | Neoplasms - complications | Neoplasm Metastasis | Neoplasms - therapy | Survival Analysis | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Patient Reported Outcome Measures
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2007, Volume 357, Issue 1, pp. 39 - 51
Journal Article
Nature genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1439 - 1445
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Estrogen Receptor alpha - chemistry | Humans | Models, Molecular | Mutation, Missense | Breast Neoplasms - drug therapy | Drug Resistance, Neoplasm - genetics | Animals | Estrogen Receptor alpha - genetics | Estrogen Antagonists - therapeutic use | MCF-7 Cells | Mice, Nude | Protein Interaction Domains and Motifs - genetics | Antineoplastic Agents, Hormonal - therapeutic use | Cell Line, Tumor | Estrogen Receptor alpha - metabolism | Female | Ligands | Mice | Mice, Inbred BALB C | Estrogens - metabolism | Receptors | Gene mutations | Estrogen | Breast cancer | Genetic aspects | Drug resistance | Identification and classification | Studies | Medical research | Clinical trials | Genomes | Mutation | Gene expression | Cancer therapies | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 5218 - 5224
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Aminopyridines - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Cyclin-Dependent Kinase 4 - genetics | Humans | Middle Aged | Cyclin-Dependent Kinase 6 - genetics | Aminopyridines - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Drug-Related Side Effects and Adverse Reactions - pathology | Disease-Free Survival | Neoplasm Metastasis | Breast Neoplasms - genetics | Benzimidazoles - administration & dosage | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Benzimidazoles - adverse effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Drug-Related Side Effects and Adverse Reactions - classification | Toxicity | Diarrhea | Fatigue | Nausea | Breast cancer | Metastasis | Cancer therapies | Patients | Survival | ErbB-2 protein | Cyclin-dependent kinase 4 | Metastases | Chemotherapy | Inhibitors | Experimental design | Quality | Medical prognosis | Response rates | Toxic diseases | Cancer | Index Medicus
Journal Article